X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (47) 47
Publication (7) 7
Newspaper Article (4) 4
Book Review (3) 3
Compact Disc (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Streaming Audio (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (20) 20
animals (19) 19
mice (11) 11
humans (9) 9
oncology (9) 9
research (9) 9
female (8) 8
colorectal cancer (7) 7
angiogenesis (6) 6
genetics (6) 6
genomic imprinting (6) 6
renin-angiotensin system - physiology (6) 6
cancer (5) 5
colorectal neoplasms - metabolism (5) 5
expression (5) 5
marsupialia - genetics (5) 5
metastasis (5) 5
mice, inbred cba (5) 5
physiological aspects (5) 5
research article (5) 5
angiotensin-converting enzyme inhibitors - pharmacology (4) 4
cancer research (4) 4
captopril (4) 4
captopril - pharmacology (4) 4
colorectal neoplasms - pathology (4) 4
development and progression (4) 4
endothelial growth-factor (4) 4
evolution (4) 4
gene expression (4) 4
gene-expression (4) 4
genetics & heredity (4) 4
liver cancer (4) 4
male (4) 4
neoplasms. tumors. oncology. including cancer and carcinogens (4) 4
renin-angiotensin system - drug effects (4) 4
tammar wallaby (4) 4
tumor-growth (4) 4
angiotensin-converting enzyme inhibitors - therapeutic use (3) 3
article (3) 3
cell proliferation - drug effects (3) 3
christmas music (3) 3
colorectal neoplasms - drug therapy (3) 3
comparative phylogenetic analysis (3) 3
developmental biology (3) 3
dna methylation (3) 3
genes (3) 3
genetic aspects (3) 3
growth (3) 3
health aspects (3) 3
ii type-1 receptor (3) 3
immunohistochemistry (3) 3
liver (3) 3
liver metastases (3) 3
liver neoplasms, experimental - metabolism (3) 3
mammalian development (3) 3
neovascularization, pathologic - drug therapy (3) 3
nitric-oxide (3) 3
placenta - metabolism (3) 3
pregnancy (3) 3
prostate-cancer (3) 3
rats (3) 3
renin-angiotensin system (3) 3
tumors (3) 3
up-regulation (3) 3
abstracts (2) 2
allelic expression (2) 2
amino acid sequence (2) 2
angiotensin (2) 2
angiotensin i - pharmacology (2) 2
angiotensin ii - pharmacology (2) 2
angiotensin ii type 1 receptor blockers - pharmacology (2) 2
angiotensin ii type 1 receptor blockers - therapeutic use (2) 2
animal structures (2) 2
antiangiogenesis (2) 2
antibodies, monoclonal - pharmacology (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antineoplastic agents - pharmacology (2) 2
antineoplastic agents - therapeutic use (2) 2
base sequence (2) 2
biological evolution (2) 2
breast cancer (2) 2
breast neoplasms - blood supply (2) 2
breast neoplasms - drug therapy (2) 2
carcinoma cells (2) 2
cells (2) 2
converting-enzyme-inhibitor (2) 2
cytology (2) 2
dependent kinase inhibitor (2) 2
disease models, animal (2) 2
drug synergism (2) 2
endocrine system diseases (2) 2
enzyme inhibitors - pharmacology (2) 2
enzymes (2) 2
gadolinium chloride (2) 2
gastroenterology & hepatology (2) 2
gene expression regulation, developmental (2) 2
gene expression regulation, neoplastic (2) 2
genomic imprinting - genetics (2) 2
genomics (2) 2
gregorian chants (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 5144 - 11
Successive rounds of chemical modification in three generations of benzopyran molecules have shown to select for different mechanisms of actions and... 
Chemical modification | Tubulin | Melanoma | Cell lines | Polymerization | Tumor cell lines | Cancer | Apoptosis | Index Medicus
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 04/2015, Volume 107, Issue 4, p. 1
Background: Matrix metalloproteinase (MMP) 14 may mediate tumor progression through vascular and immune-modulatory effects. Methods: Orthotopic murine breast... 
VASCULAR NORMALIZATION | INVASION | CANCER CELLS | ANGIOGENESIS | ONCOLOGY | MATRIX-METALLOPROTEINASE INHIBITORS | DRUG-DELIVERY | NITRIC-OXIDE SYNTHASE | TUMOR-GROWTH | EXPRESSION | BETA | Up-Regulation | Immunoglobulin G - blood | Breast Neoplasms - immunology | Humans | Gene Expression Regulation, Neoplastic | Neovascularization, Pathologic | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Smad3 Protein - metabolism | Breast Neoplasms - metabolism | Nitric Oxide Synthase Type II - antagonists & inhibitors | Dose Fractionation | Female | Antineoplastic Agents - pharmacology | Matrix Metalloproteinase 14 - drug effects | Antibodies, Monoclonal - pharmacology | Enzyme Inhibitors - pharmacology | Smad2 Protein - metabolism | Nitric Oxide Synthase Type II - drug effects | Breast Neoplasms - blood supply | Matrix Metalloproteinase 14 - metabolism | Breast Neoplasms - drug therapy | Enzyme Inhibitors - therapeutic use | Macrophages - enzymology | Gene Expression Regulation, Enzymologic | Breast Neoplasms - radiotherapy | Phenotype | Animals | Signal Transduction - drug effects | Mammary Neoplasms, Experimental | Cell Line, Tumor | Macrophages - drug effects | Amidines - pharmacology | Mice | Benzylamines - pharmacology | Transforming Growth Factor beta - metabolism | Nitric Oxide Synthase Type II - metabolism | Enzymes | Genotype & phenotype | Immunoglobulins | Immunology | Radiation therapy | Gene expression | Tumors | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences, ISSN 0027-8424, 11/2012, Volume 109, Issue 45, pp. E3119 - E3127
Brain metastases are a serious obstacle in the treatment of patients with human epidermal growth factor receptor-2 ( HER2 )–amplified breast cancer. Although... 
targeted therapy | CELLS | TRASTUZUMAB | ANGIOGENESIS | BEVACIZUMAB | MULTIDISCIPLINARY SCIENCES | PHASE-II | COMBINATION | CAPECITABINE | NERVOUS-SYSTEM METASTASES | tumor-stroma interaction | tumor microenvironment | antiangiogenesis | LAPATINIB GW572016 | treatment resistance | ENDOTHELIAL GROWTH-FACTOR | Receptor, ErbB-2 - genetics | Blood Vessels - pathology | Humans | Brain Neoplasms - pathology | Receptor, ErbB-2 - metabolism | Antibodies, Monoclonal - therapeutic use | Brain Neoplasms - blood supply | Killer Cells, Natural - pathology | Molecular Targeted Therapy | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Necrosis | Brain Neoplasms - secondary | Receptors, Vascular Endothelial Growth Factor - metabolism | Antibodies, Monoclonal, Humanized - pharmacology | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Female | Receptor, ErbB-2 - antagonists & inhibitors | Cell Death - drug effects | Disease Models, Animal | Antibodies, Monoclonal, Humanized - therapeutic use | Antibodies, Monoclonal - pharmacology | Treatment Outcome | Brain Neoplasms - drug therapy | Breast Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Diagnostic Imaging | Animals | Gene Amplification | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neovascularization, Pathologic - drug therapy | Quinazolines - therapeutic use | Blood Vessels - drug effects | Survival Analysis | Cell Proliferation - drug effects | Killer Cells, Natural - drug effects | Mice | Quinazolines - pharmacology | Trastuzumab | Brain | Breast cancer | Metastasis | Medical treatment | Tumors | Index Medicus | Biological Sciences | PNAS Plus | tumor–stroma interaction
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 08/2013, Volume 105, Issue 16, pp. 1188 - 1201
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 10/2016, Volume 31, Issue 10, pp. 1773 - 1782
Journal Article
BMC Cancer, ISSN 1471-2407, 06/2011, Volume 11, Issue 1, pp. 274 - 274
Background: Targeting of the renin angiotensin system (RAS) reduces tumour growth in experimental models of cancer. We aimed to establish if combined targeting... 
Biomarker | Liver metastases | Renin angiotensin system | Combination therapy | SYSTEM | ANGIOGENESIS | CELL-PROLIFERATION | renin angiotensin system | biomarker | ANGIOTENSIN-II TYPE-1 | RECEPTOR BLOCKER | ONCOLOGY | PROSTATE-CANCER | MOUSE MODEL | GROWTH | combination therapy | EXPRESSION | liver metastases | Up-Regulation | Vascular Endothelial Growth Factor A - biosynthesis | Tetrazoles - pharmacology | Captopril - pharmacology | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Colorectal Neoplasms - genetics | Neoplasm Proteins - physiology | Gene Expression Regulation, Neoplastic | Angiotensin I - therapeutic use | Drug Resistance, Neoplasm | Neoplasm Proteins - antagonists & inhibitors | Peptide Fragments - pharmacology | Molecular Targeted Therapy | Vascular Endothelial Growth Factor A - genetics | Angiotensin II Type 1 Receptor Blockers - pharmacology | Biomarkers, Tumor | Biphenyl Compounds - therapeutic use | Captopril - therapeutic use | Liver Neoplasms, Experimental - metabolism | Receptor, Angiotensin, Type 1 - genetics | Adenocarcinoma - metabolism | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Biphenyl Compounds - pharmacology | Receptor, Angiotensin, Type 1 - biosynthesis | Colorectal Neoplasms - drug therapy | Mice, Inbred CBA | Adenocarcinoma - genetics | Angiotensin I - pharmacology | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Liver Neoplasms, Experimental - genetics | Receptor, Angiotensin, Type 1 - drug effects | Colorectal Neoplasms - metabolism | Receptor, Angiotensin, Type 2 - agonists | Renin-Angiotensin System - physiology | Tumor Burden | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Drug Synergism | Animals | Liver Neoplasms, Experimental - drug therapy | Neovascularization, Pathologic - drug therapy | Tetrazoles - therapeutic use | Mice | Peptide Fragments - therapeutic use | Oligopeptides - pharmacology | Drug Screening Assays, Antitumor | Prevention | Liver cancer | Captopril | Angiotensin | Colorectal cancer | Development and progression | Research | Drug therapy | Health aspects | Risk factors | Index Medicus
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 10/2016, Volume 31, Issue 10, pp. 1773 - 1782
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 5102 - 5102
Journal Article
Cancer Cell International, ISSN 1475-2867, 06/2010, Volume 10, Issue 1, pp. 19 - 19
Background: Blockade of the angiotensin (ANG) II type 1 receptor (AT1R) inhibits tumour growth in several cancers, including colorectal cancer (CRC) liver... 
CELLS | ONCOLOGY | PROSTATE-CANCER | NITRIC-OXIDE | RATS | MICE | ANGIOGENIC INHIBITOR | TUMOR ANGIOGENESIS | MODEL | EXPRESSION | ENDOTHELIAL GROWTH-FACTOR | Liver cancer | Care and treatment | Oncology, Experimental | Colorectal cancer | Metastasis | Research | Risk factors | Cancer
Journal Article
Cancer Cell International, ISSN 1475-2867, 10/2010, Volume 10, Issue 1, pp. 37 - 37
  Blockade of the angiotensin (ANG) II type 1 receptor (AT1R) inhibits tumour growth in several cancers, including colorectal cancer (CRC) liver metastases.... 
Journal Article
Journal of Surgical Research, ISSN 0022-4804, 2013, Volume 179, Issue 1, pp. 66 - 71
Journal Article
Journal Article